-+ 0.00%
-+ 0.00%
-+ 0.00%

Seres Therapeutics: Q3 Earnings Snapshot

Barchart·11/04/2026 06:12:53
Listen to the news

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Seres Therapeutics Inc. (MCRB) on Wednesday reported a loss of $16.3 million in its third quarter.

The Cambridge, Massachusetts-based company said it had a loss of $1.63 per share. Losses, adjusted for asset impairment costs, came to $1.06 per share.

The drug developer posted revenue of $593,000 in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MCRB at https://www.zacks.com/ap/MCRB